Similar articles

• Patient-selected goals in overactive bladder: a placebo controlled randomized double-blind trial of transdermal oxybutynin for the treatment of urgency and urge incontinence.

  Cartwright R, Srikrishna S, Cardozo L, Robinson D. Cartwright R, et al. BJU Int. 2011 Jan;107(1):70-6. doi: 10.1111/j.1464-410X.2010.09508.x. BJU Int. 2011. PMID: 20626389 Clinical Trial.
• Idiopathic urgency urinary incontinence.

  Keller DL. Keller DL. N Engl J Med. 2010 Dec 30;363(27):2672; author reply 2672. doi: 10.1056/NEJMc1011633. N Engl J Med. 2010. PMID: 21190469 No abstract available.
• Efficacy of oral extended-release oxybutynin in cognitively impaired older nursing home residents with urge urinary incontinence: a randomized placebo-controlled trial.

  Lackner TE, Wyman JF, McCarthy TC, Monigold M, Davey C. Lackner TE, et al. J Am Med Dir Assoc. 2011 Nov;12(9):639-47. doi: 10.1016/j.jamda.2010.05.003. Epub 2010 Oct 2. J Am Med Dir Assoc. 2011. PMID: 21450183 Clinical Trial.
• Transdermal oxybutynin: sticking to the facts.

  Cartwright R, Cardozo L. Cartwright R, et al. Eur Urol. 2007 Apr;51(4):907-14; discussion 914. doi: 10.1016/j.eururo.2006.11.033. Epub 2006 Nov 27. Eur Urol. 2007. PMID: 17157979 Review.
• Oxybutynin for treatment of urge urinary incontinence and overactive bladder: an updated review.

  Abramov Y, Sand PK. Abramov Y, et al. Expert Opin Pharmacother. 2004 Nov;5(11):2351-9. doi: 10.1517/14656566.5.11.2351. Expert Opin Pharmacother. 2004. PMID: 15500382 Review.